Key Takeaways
- A quarter defined by a delayed deal: Revenue and PAT declined sequentially after a large healthcare deal slipped past Q4, forcing the company to carry unutilized on-site capacity and deal-pursuit costs through the quarter.
- The largest client is back: The top high-tech account, a drag in prior quarters, has returned to growth and management expects it to regain its highest-ever run rate during the year, though with a different revenue mix.
- Pipeline is healthy but cycles are longer: A new large-deal win in US banking and a multiyear GenAI engagement were bright spots, but management flagged that deals once closing in 3–6 months now take 6–9 months or more, a dynamic it expects to persist for another 1–2 quarters.
- Margins fell 300 bps and stay under pressure: The delayed deal, continued AI and Fabric investments, and a seasonal Quant dip combined to push international EBITDA before ForEx to 17.3%; management sees margins staying at similar levels for at least two more quarters.
- What to watch next quarter: Whether the delayed healthcare deal closes and redeployment begins, whether Q1 delivers the promised flat-to-slightly-up outcome, and any signal on the FY25 growth range when management recalibrates in July.
The Delayed Healthcare Deal: What Happened and What It Costs
- Verbal commitment, then a March reversal: Sonata had ramped up on-site headcount from January based on a verbal agreement; the client, an existing healthcare organization, deferred the decision past Q4 due to its own organizational and leadership changes.
- Revenue and cost hit combined: The deal was expected to book in January, so its absence directly reduced Q4 revenue while the pre-built on-site team raised costs, a double impact management declined to quantify in detail.
- Utilization rose for the wrong reason: Reported utilization improved 1.6% QoQ, but only because the offshore component of the large-deal team was not needed, not because demand absorbed idle bench; on-site costs remained elevated.
- Talent is fungible, recovery is a redeployment story: Management says the people invested in for this deal can be redeployed across other large deals in the pipeline, and expects margin recovery within one to two quarters, with two quarters as the outer limit.
- The deal is not dead: The opportunity remains active and could close this quarter or next; the pipeline contains other large deals that can absorb the capacity if it does not.
Samir Dhir: "We had ramped up literally from January onwards. There was a verbal agreement with the customer to move forward, but we got to know that the deal is not happening towards the mid-March time frame."
Demand Environment and Deal Dynamics
- Sector-level divergence: BFSI and retail stayed flat to moderate, constrained by ongoing headwinds; high tech showed green shoots led by the largest client's recovery; healthcare is expected to follow.
- Deal cycles have structurally lengthened: Deals that previously closed in 3–6 months now take 6–9 months or longer, a shift management attributes to the last three months and expects to continue for another 1–2 quarters.
- Large-deal pipeline remains the anchor: Data and cloud work represents roughly 40% of the total pipeline; the biggest active pursuits span a European telecom, a London-based private healthcare organization, an Australian heavy-equipment supplier, and a Fortune 200 US financial firm.
- New wins provide offsetting evidence: A large-deal win at a top-10 US asset-under-management bank for a Customer 360 build across all lines of business, plus a multiyear GenAI program for a clinical-trial productivity client, demonstrate that deals are still closing, just more slowly.
- Customer concentration amplified the softness: The top 10 and top 20 client cohorts weakened for two straight quarters, driven by the second-largest travel customer in Europe and moderation in three to four other top-10 accounts.
Samir Dhir: "And I guess, as I said at the beginning the cycle has changed, I would say, the last 3 months, the deals which are closing between 3 to 6 months and now closing between 6 to 9 months or further."
Largest Client Recovery and Vertical Mix
- From green shoots to a mini plant: The largest high-tech client, which had been a drag, is back on a growth trajectory; management expects the account to return to its highest-ever run rate over the course of the year.
- Different mix, different use case: The revenue growth in this account is strong and carries significant opportunity, but it comes with a different service mix and use case than the prior peak, implying a possible margin or revenue-quality shift that was not quantified.
- BFSI seasonality in Quant: The sharp sequential drop in BFSI revenue from $17M to $11.5M reflects Quant's seasonal pattern with a large banking client, where January–March is always soft, a dynamic communicated in the prior quarter's call.
- Microsoft Dynamics lags license sales: The practice saw a double-digit YoY decline even as Microsoft reported double-digit license growth; management attributes the gap to the normal lag between license procurement and implementation services, with normalization expected in 1–2 quarters.
- Emerging verticals are project-lumpy: The drop from $6.7M to $3.5M in emerging verticals is project-specific; most large deals concentrate in the four major verticals, so emerging will automatically moderate when large-deal activity is high.
Samir Dhir: "The largest client, the high-tech client is back on growth. If you recall, last quarter, we shared with you guys that we are seeing green shoots of growth. And I think those green shoots of growth have become a mini plant."
Margin Walk and Cost Structure
- 300 bps of margin compression: International EBITDA before ForEx and other income fell to 17.3%, driven primarily by the delayed deal's unutilized on-site capacity, revenue not growing across other large deals, and continued investment in AI and Microsoft Fabric.
- Other expenses jumped on deal costs and reclassification: Other expenses rose to INR 230 crore from INR 186 crore sequentially, a move management attributed partly to deal-pursuit costs and partly to accounting reclassification requirements, with a full-year comparison needed for clarity.
- Margin recovery is a second-half story: Management expects margins to stay at similar levels for at least two more quarters, with improvement possible only in Q3 and Q4, contingent on redeploying the people invested in for the delayed deal.
- Wage hike decision pending: The company will decide on its increment cycle by the end of Q1 and announce the quantum and timing then, adding a potential cost headwind to the near-term margin outlook.
- Finance costs may ease with a lag: Unwinding of interest on deferred payouts will come down after the payout this quarter, but a loan closure delayed by RBI issues means the net cost benefit may not materialize for a couple of quarters.
Jagannathan CN: "So at least in a couple of quarters, the margin may remain at a similar level and the improvement we can see probably in the second half of the year towards the Q3 and Q4, probably we can expect some improvement."
Strategic Initiatives and AI Positioning
- Sonata Harmoni.AI now on both major hyperscaler marketplaces: The enterprise AI platform is listed on Azure and AWS, with Amazon Bedrock and related services integrated, expanding its addressable distribution.
- GenAI is moving from PoC to multiyear programs: A key win involves implementing modern engineering enabled by GenAI to improve clinical-trial productivity and quality, plus building a governance framework for the client's GenAI usage, structured as a multiyear engagement.
- Fabric capability is being monetized: A SaaS enterprise win for implementing Microsoft Fabric covers creating and configuring the Fabric environment for advanced automated reporting and visualization on the client's proprietary products.
- 20% of revenue from AI services in three years: Management set a public target for AI to become a material revenue line, though no current AI revenue base was disclosed to anchor the ambition.
- Talent is being certified at scale: Over 50% of Sonatians are now Level 1 GenAI certified, with the workforce progressing toward Level 2 and Level 3 certifications, building the delivery capacity to support the AI revenue ambition.
- Geographic expansion continues: Services were expanded into four new geographies: Mexico, Poland, Egypt, and Malaysia, broadening the delivery and sales footprint.
Acquisitions, Domestic Business, and the $1.5B Goal
- Quant and Encore are integrated and performing: Both acquisitions overperformed and are fully integrated; Quant carries a seasonal Q4 softness that was anticipated and communicated, while cross-selling across entities makes it difficult to split organic from acquired growth.
- Domestic Q4 decline is structural, not alarming: Q3 is traditionally the strongest quarter for the domestic business because annual contracts close then; Q4 is always a decline quarter, a pattern holding for several years, while YoY growth at the gross-contribution level remains strong.
- Domestic moderation also reflects IT-industry exposure: Roughly 40% of domestic business turnover comes from the IT industry itself, so the broader IT services slowdown feeds into domestic performance.
- The $1.5 billion goal is delayed, not abandoned: Management is still running for the FY26 international-business target of a $0.5 billion run rate, but now expects a delay of one to two quarters, making FY27 the more realistic timeframe.
- No M&A planned this calendar year: The company will not pursue acquisitions in the current calendar year; it may evaluate equity-funded M&A starting next year, contingent on finding the right property.
Samir Dhir: "Yes, it's a great question. I think something that we keep thinking about. I think, yes, in the long term, we think we are still rooting for that goal and gunning for that goal. There might be a quarter or 2 delay in our current calibration, but we're still running for that goal."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Q1 FY25 revenue | Flat to slightly up sequentially | Q1 FY25 (update in July) |
| FY25 full-year growth | Higher than the industry; range (high-single-digit to mid-teen) to be calibrated and disclosed later | FY25 |
| Margin recovery | Redeploy delayed-deal talent; margin uptick within 1–2 quarters from now | Outer limit: 2 quarters |
| Margin trajectory | Remain at similar levels for at least 2 quarters; improvement possible in H2 | Q3/Q4 FY25 |
| Largest client run rate | Return to highest-ever run rate | During FY25 |
| Delayed healthcare deal | Still active; may close this quarter or next | Q1 or Q2 FY25 |
| Microsoft Dynamics growth | Growth trend back to normal | 1–2 quarters |
| $1.5B international run-rate goal | Achieved with 1–2 quarter delay vs. original FY26 target | FY27 |
| Wage increment decision | Quantum and timing to be announced | By end of Q1 FY25 |
| M&A activity | No M&A planned | Calendar year 2024 |
| Domestic business growth | 15% YoY growth on gross contribution maintained | Ongoing |
Key Metrics
| Metric | Q4 FY24 |
|---|---|
| International Services revenue | Degrew 2.4% sequentially, grew 24.1% YoY |
| International Services constant currency revenue | Declined 2.2% sequentially, grew 24.3% YoY |
| International business revenue (INR) | Degrew 2.6% QoQ, grew 39.5% for FY24 |
| Consolidated PAT | ₹110.4 cr, down from ₹128.4 cr in Q3 |
| International EBITDA before ForEx and other income | 17.3%, decline of 300 bps QoQ |
| Consolidated EPS | ₹4 after 1:1 bonus issue adjustment, down from ₹4.6 in Q3 |
| Consolidated ROCE | 25.4% at year-end |
| Consolidated RONW | 31.4% at year-end |
| Domestic business gross contribution | ₹64.8 cr, grew 18.6% YoY |
| Domestic PAT | Degrew 5.9% QoQ, grew 15.7% YoY |
| Full-year FY24 revenue growth | 34.3% YoY |
| Book-to-bill (international business) | 1.22x |
| Large deal pipeline growth | Up 34% QoQ |
| Utilization | 87.4%, improved 1.6 ppt QoQ |
| Overall attrition | 14% |
| Headcount | 6,416 net of attrition |
| DSO | 45 days, collections over $80.5 million |
| Clients over $3 million annual run rate | 16, up from 12 a year ago |
| Clients over $5 million annual run rate | 11 |
| New customers added | 18 |
| Top 10 client revenue contribution | 52%, down from 53.6% in Q3 |
| Revenue mix: TMT | 36% |
| Revenue mix: Retail and manufacturing | 35% |
| Revenue mix: BFSI | 14% |
| Revenue mix: Healthcare and life sciences | 12% |
| Revenue mix: Emerging | 4% |
| Offering mix: Cloud | 36% |
| Offering mix: Dynamics | 24% |
| Offering mix: Data | 22% |
| AI pipeline | Over $65 million across 90-plus clients and prospects |
| Microsoft Fabric pipeline | $42 million across 75-plus clients |
| Final dividend declared | ₹4.40 per share |